137 related articles for article (PubMed ID: 21244753)
41. A selective peroxisome proliferator-activated receptor-β/δ agonist attenuates neointimal hyperplasia after wire-mediated arterial injury.
Hamaya R; Ogawa M; Suzuki J; Kobayashi N; Hirata Y; Nagai R; Komuro I; Isobe M
Expert Opin Investig Drugs; 2013 Sep; 22(9):1095-106. PubMed ID: 23915387
[TBL] [Abstract][Full Text] [Related]
42. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
[TBL] [Abstract][Full Text] [Related]
43. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
44. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
Han S; Ritzenthaler JD; Zheng Y; Roman J
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
[TBL] [Abstract][Full Text] [Related]
45. Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway.
Jiménez R; Sánchez M; Zarzuelo MJ; Romero M; Quintela AM; López-Sepúlveda R; Galindo P; Gómez-Guzmán M; Haro JM; Zarzuelo A; Pérez-Vizcaíno F; Duarte J
J Pharmacol Exp Ther; 2010 Feb; 332(2):554-61. PubMed ID: 19906781
[TBL] [Abstract][Full Text] [Related]
46. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
47. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
48. The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
Harrington LS; Moreno L; Reed A; Wort SJ; Desvergne B; Garland C; Zhao L; Mitchell JA
PLoS One; 2010 Mar; 5(3):e9526. PubMed ID: 20209098
[TBL] [Abstract][Full Text] [Related]
49. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
50. GW0742, a high-affinity PPAR-δ agonist, mediates protection in an organotypic model of spinal cord damage.
Esposito E; Paterniti I; Meli R; Bramanti P; Cuzzocrea S
Spine (Phila Pa 1976); 2012 Jan; 37(2):E73-8. PubMed ID: 21685825
[TBL] [Abstract][Full Text] [Related]
51. PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742.
Faiola B; Falls JG; Peterson RA; Bordelon NR; Brodie TA; Cummings CA; Romach EH; Miller RT
Toxicol Sci; 2008 Oct; 105(2):384-94. PubMed ID: 18593727
[TBL] [Abstract][Full Text] [Related]
52. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
[TBL] [Abstract][Full Text] [Related]
53. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
[TBL] [Abstract][Full Text] [Related]
54. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
55. ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha IN THE DEVELOPMENT OF BLEOMYCIN-INDUCED LUNG INJURY.
Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Caputi AP; Cuzzocrea S
Shock; 2005 Dec; 24(6):547-55. PubMed ID: 16317386
[TBL] [Abstract][Full Text] [Related]
56. High sugar intake and development of skeletal muscle insulin resistance and inflammation in mice: a protective role for PPAR- δ agonism.
Benetti E; Mastrocola R; Rogazzo M; Chiazza F; Aragno M; Fantozzi R; Collino M; Minetto MA
Mediators Inflamm; 2013; 2013():509502. PubMed ID: 23861559
[TBL] [Abstract][Full Text] [Related]
57. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
[TBL] [Abstract][Full Text] [Related]
58. A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease.
Das NR; Gangwal RP; Damre MV; Sangamwar AT; Sharma SS
Curr Neurovasc Res; 2014 May; 11(2):114-24. PubMed ID: 24635117
[TBL] [Abstract][Full Text] [Related]
59. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus.
Romero M; Toral M; Robles-Vera I; Sánchez M; Jiménez R; O'Valle F; Rodriguez-Nogales A; Pérez-Vizcaino F; Gálvez J; Duarte J
Hypertension; 2017 Apr; 69(4):641-650. PubMed ID: 28242713
[TBL] [Abstract][Full Text] [Related]
60. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
Dunn SE; Bhat R; Straus DS; Sobel RA; Axtell R; Johnson A; Nguyen K; Mukundan L; Moshkova M; Dugas JC; Chawla A; Steinman L
J Exp Med; 2010 Aug; 207(8):1599-608. PubMed ID: 20624891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
